Apheresis Consumables And Equipment Market Report 2026

Apheresis Consumables And Equipment Market Overview

• Apheresis Consumables And Equipment market size has reached to $3.76 billion in 2025 • Expected to grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Increasing Global Blood Disorders Drive Demand For Apheresis Equipment And Consumables Market • Market Trend: New Updates To Provide A More Versatile Treatment Option • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Apheresis Consumables And Equipment Market?

Apheresis consumables and equipment are devices through which the blood drawn from a donor is separated into its components through plasma exchange, stem cell harvest, photopheresis, and low-density lipid removal techniques. Further, the required components like plasma or platelets are retained and the remaining is passed to the circulation. The main products of apheresis consumables and equipment are disposables and devices. The apheresis consumables are the products that are used in apheresis technology. The technologies involved in disposables and devices are centrifugation and membrane filtration and the procedures involved are photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others. The apheresis consumables and equipment are used in applications such as renal disease, neurology, hematology, and others.

What Is The Apheresis Consumables And Equipment Market Growth Forecast?

The apheresis consumables and equipment market size is expected to see rapid growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in automated apheresis devices, rising demand for plasma-derived therapies, expansion of stem cell collection procedures, increasing regulatory compliance for disposables and devices, integration with digital monitoring and IoT-enabled systems. Major trends in the forecast period include rising demand for automated apheresis devices, increased use of disposable kits and tubing sets, expansion of plasma and plateletpheresis procedures, adoption of advanced centrifugation and membrane filtration technologies, growing focus on patient safety and blood component quality.

What Are The Drivers Of The Apheresis Consumables And Equipment Market?

The cases of blood disorders are on the rise globally, creating a need for blood transfusions. Apheresis Equipment helps to transfuse blood for blood disorders like sickle cell anemia, leukemia, and cancer. According to a report published by the Leukemia and Lymphoma Society, 60,300 people in the USA are expected to be diagnosed with leukemia, and one person is diagnosed with blood cancer every 3 minutes requiring an immediate blood transfusion. According to the American Society of Hematology, 100,000 Americans possess sickle cell Anemia and another 2 million people carry the trait requiring Apheresis Equipment for blood transfusion. According to the International Agency for Research on Cancer (IARC), by 2040, 16.3 million new cancer cases are expected to be reported worldwide. Cancer treatment requires at least 8 units of blood per patient per procedure, thus requiring blood component collection and blood transfusion. Thus, such a high prevalence of these blood disorders increases demand for apheresis consumables and equipment industry. The rise in chronic conditions is expected to propel the apheresis consumables and equipment market going forward. Chronic conditions, also known as chronic diseases, refer to long-term health conditions that last for extended periods, often for a person's entire life, and typically cannot be cured completely. Apheresis consumables and equipment are crucial for managing chronic diseases by facilitating targeted removal or collection of blood components in chronic conditions including autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvesting. For instance, in 2023, according to the National Library of Medicine, a US-based government medical library, by 2035, nearly 36% of US adults aged 50 and older are projected to have at least one chronic condition, with this number anticipated to rise to almost 48% by 2050. Therefore, the rise in chronic conditions is driving the apheresis consumables and equipment industry.

Key Players In The Global Apheresis Consumables And Equipment Market

Major companies operating in the apheresis consumables and equipment market are Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, Braun Melsungen AG, Therakos Inc., HemaCare Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Medica SpA, Terumo Corporation, Macopharma, Grifols S.A., Baxter International Inc., Fenwal Inc., Miltenyi Biotec GmbH, Infomed SA, Lmb Technologie GmbH, Medivators Inc., Nigale Biomedical Inc., Aferetica S.r.l., Apheresis Care Group, Beijing Meso-Tech Co. Ltd., Biegler GmbH, Brightwake Ltd., Cytosorbents Corporation, DePuy Synthes Companies, Guangzhou Daji Medical Science and Technology Co. Ltd., Haier Biomedical

Global Apheresis Consumables And Equipment Market Trends and Insights

Major companies operating in apheresis consumables and equipment are launching new versions such as the amicus extracorporeal photopheresis single-needle option to provide versatile therapy. The Amicus Extracorporeal Photopheresis single-needle option is an updated feature of the Amicus Extracorporeal Photopheresis (ECP) System that allows for the collection and return of blood components through a single venous access point during the photopheresis procedure. For instance, in April 2023, Fresenius Kabi, a Germany-based healthcare company launched the single-needle option for the Amicus Extracorporeal Photopheresis (ECP) System. The update for the Amicus ECP system includes new software versions for the Amicus Separator and Phelix Photoactivation Device, along with a disposable kit for either single or double-needle venous access. This enhancement allows for more versatile treatment, especially benefiting patients with limited venous access. The system's primary therapeutic application is extracorporeal photopheresis, a leukapheresis-based treatment for cutaneous T-cell lymphoma (CTCL).

What Defines the Apheresis Consumables And Equipment Market?

The apheresis consumables and equipment market consists of sales of equipment and consumables. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Apheresis Consumables And Equipment Market Report 2026?

The apheresis consumables and equipment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis consumables and equipment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.